Skip to content

Clinical trials

Terminated Dyslipidemias trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Status: Terminated Country / region: United States Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20063
20072
20081
20091
20112
20132
20151
20161
20173
20191
20201
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda3
Columbia University2
Pfizer2
AstraZeneca1
Boston Children's Hospital1
Boston University1
Corewell Health East1
Eli Lilly and Company1
Gloria Vega1
Kowa Research Institute, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias24
Hypertension6
Metabolic Syndrome5
Obesity5
Diabetes Mellitus4
Hyperlipidemias4
Insulin Resistance4
Cardiovascular Diseases3
Hypercholesterolemia3
Overweight3

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.